US 12,295,957 B2
Ascorbic acid and quinone compounds in combination with an antiparasitic agent for treating a parasitic disease
Sueli de Oliveira Silva Lautenschlager, Maringa (BR); Vania Cristina Desoti, Palotina (BR); Celso Vataru Nakamura, Maringa (BR); and Valdecir Farias Ximenes, Bauru (BR)
Assigned to IC-MedTech Corp., Las Vegas, NV (US)
Filed by IC-MedTech Corp., Las Vegas, NV (US)
Filed on Jan. 15, 2024, as Appl. No. 18/412,805.
Application 18/412,805 is a continuation of application No. 16/972,004, granted, now 11,872,233, previously published as PCT/US2019/035501, filed on Jun. 5, 2019.
Claims priority of provisional application 62/681,500, filed on Jun. 6, 2018.
Prior Publication US 2024/0165084 A1, May 23, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/541 (2006.01); A61K 9/00 (2006.01); A61K 31/122 (2006.01); A61K 31/345 (2006.01); A61K 31/375 (2006.01); A61K 31/4168 (2006.01); A61K 31/4184 (2006.01); A61K 45/06 (2006.01); A61P 33/00 (2006.01)
CPC A61K 31/541 (2013.01) [A61K 9/0056 (2013.01); A61K 31/122 (2013.01); A61K 31/345 (2013.01); A61K 31/375 (2013.01); A61K 31/4168 (2013.01); A61K 31/4184 (2013.01); A61K 45/06 (2013.01); A61P 33/00 (2018.01)] 20 Claims
OG exemplary drawing
 
1. A method of treating or alleviating one or more symptoms of a parasitic disease in a subject, comprising administering to the subject: (i) ascorbic acid, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt thereof; (ii) a quinone compound, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt thereof; and (iii) an antiparasitic agent.